Sign in
4

Changes in Ownership

NEUROCRINE BIOSCIENCES INC Filed Acc 0001209191-22-005109

Director sold 15,000 shares at $74.43 ($1,116,378)

  • Director acquired 15,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

SHERWIN STEPHEN A · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-01-24 Exercise or conversion : show line 1 in the form +15,000 $6.66 $99,900 40,055 D
2022-01-24 Sale : show line 2 in the form −15,000 $74.43 $1,116,378 25,055 D
Open-market sales · 15,000 sh · avg $74.43 · $1,116,378

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-01-24 Exercise or conversion : show line 3 in the form Non-Qualified Stock Option −15,000 $6.66 $99,900 0 D
Loading xslF345X03/doc4.xml…